All News #Library
Biotech
Nimbus Therapeutics To Unveil SIK2 Inhibitors Data At ECCO
17 Feb 2026 //
BUSINESSWIRE
Nimbus Therapeutics Completes Dose Escalation In Phase 1/2 Trial
19 Dec 2025 //
PHARMIWEB
Nimbus Therapeutics Starts First-in-Human Trial with NDI-219216
25 Apr 2025 //
BUSINESSWIRE
Nimbus Therapeutics Appoints Abbas as Chief Executive Officer
07 Mar 2025 //
BUSINESSWIRE
Nimbus Therapeutics Achieves Milestone in Collaboration with Lilly
25 Feb 2025 //
BUSINESSWIRE
Nimbus Updates Oncology Pipeline Progress & Shares Business Updates
09 Jan 2025 //
BUSINESSWIRE
Nimbus Presents Updated HPK1 Inhibitor Data at SITC 2024
07 Nov 2024 //
BUSINESSWIRE
Nimbus To Present Werner Syndrome Helicase Program Data
09 Oct 2024 //
BUSINESSWIRE

Market Place
Sourcing Support